Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Molecular Oncology|November 15, 2012
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunityLetizia Porcelli, Anna E Quatrale, Paola Mantuano, et al.
Bulletin Du Cancer|July 1, 1996
[Predictive value of the hemogram for myelotoxicity induced by the association of carboplatin-fluorouracil on the 4th day of the therapeutic regimen]P Cappelaere, C Fournier, F Rolland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomasR Fety, F Rolland, M Barberi-Heyob, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 22, 2013
Initial staging for squamous cell carcinoma of the mouth, larynx and pharynx (except nasopharynx). Part 3: general assessment. 2012 SFORL recommendationsE de Monès, S Vergez, B Barry, et al.
ESMO Open|November 7, 2025
MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancerE Borcoman, A Hervieu, C Cropet, et al.
International Journal of Obesity (2005)|February 25, 2009
Prevalence of overweight in 6- to 15-year-old children in central/western France from 1996 to 2006: trends toward stabilizationS Péneau, B Salanave, L Maillard-Teyssier, et al.
Bulletin Du Cancer|September 12, 2009
[Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy]E Bardet, J Bourhis, L Cals, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 6, 2014
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trialK Fizazi, G Gravis, A Flechon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancerX Pivot, A Awada, D Gedouin, et al.
British Journal of Pharmacology|February 18, 2009
Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC-1 channel regulation and expressionS Pierno, G M Camerino, V Cippone, et al.
Pageof 10